HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Filomena Anna Digilio Selected Research

human SLC22A5 protein

10/2020The Discovery of Highly Potent THP Derivatives as OCTN2 Inhibitors: From Structure-Based Virtual Screening to In Vivo Biological Activity.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Filomena Anna Digilio Research Topics

Disease

4Huntington Disease (Huntington's Disease)
05/2022 - 01/2019
2Neurodegenerative Diseases (Neurodegenerative Disease)
05/2022 - 12/2020
2Mitochondrial Diseases (Mitochondrial Disease)
10/2020 - 01/2019

Drug/Important Bio-Agent (IBA)

3Carnitine (L-Carnitine)FDA LinkGeneric
05/2022 - 10/2020
23-(2,2,2-trimethylhydrazine)propionateIBA
10/2020 - 01/2019
1Proteins (Proteins, Gene)FDA Link
05/2022
1Carnitine O-Palmitoyltransferase (Carnitine Palmitoyltransferase II)IBA
05/2022
1Huntingtin ProteinIBA
04/2022
1human SLC22A5 proteinIBA
10/2020
1Peroxisome Proliferator-Activated Receptors (PPAR)IBA
01/2019